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X chromosome inactivation and genomic imprinting are classic epigenetic processes that cause
disease when not appropriately regulated in mammals. Whereas X chromosome inactivation
evolved to solve the problem of gene dosage, the purpose of genomic imprinting remains contro-
versial. Nevertheless, the two phenomena are united by allelic control of large gene clusters,
such that only one copy of a gene is expressed in every cell. Allelic regulation poses significant
challenges because it requires coordinated long-range control in cis and stable propagation over
time. Long noncoding RNAs have emerged as a common theme, and their contributions to diseases
of imprinting and the X chromosome have become apparent. Here, we review recent advances
in basic biology, the connections to disease, and preview potential therapeutic strategies for future
development.Introduction
Every organism faces the challenge of regulating gene dosage.
In diploids, genes are generally assumed to be expressed from
both alleles but, in mammals, several classes of genes are ex-
pressed from only one allele per cell. Two of the most prominent
examples of allelic phenomena are X chromosome inactivation
(XCI) and genomic imprinting. Because of XCI, only one copy
of each X-linked gene is active in female cells (XX). Because
male cells carry only one X chromosome (XY), they are inherently
hemizygous for all X-linked genes. In genomic imprinting,
genes within a discrete domain are coordinately regulated and
expressed according to parent of origin. Research over the
past 50 years has identified many similarities between XCI and
genomic imprinting. Apart from monoallelic expression, genes
subject to the two processes tend to cluster, are influenced at
long-range by a master control region, and are associated with
multiple long noncoding RNAs (lncRNA). Some of the most
fascinating stories to emerge in recent years have been related
to lncRNAs as master regulators. Some of the first epigenetic
lncRNAs in mammals were, in fact, identified from genomic
imprinting and XCI studies. Such lncRNAs have been proposed
to serve as recruiting tools for chromatin-modifying complexes
that would in turn silence or activate genes residing within the
allelically regulated clusters.
Together, XCI and imprinting affect expression of 5%–10%
of genes in the mammalian genome. From a functional stand-
point, mutations within these regions could be easily unmasked,
as they are often unbuffered by contributions from the silenced
wild-type copy and could thereby cause severe developmental
defects. This explains why X-linked and imprinted diseases
are among the most common congenital human disorders,
accounting for easily recognizable childhood syndromes such1308 Cell 152, March 14, 2013 ª2013 Elsevier Inc.as Rett, fragile X, Prader-Willi/Angelman, and Beckwith-Wiede-
mann syndromes, as well as conditions such as hemophilia,
testicular feminization, and red-green color blindness. More
recently, imprinting and X-linked anomalies have also been of
interest for stem cell maturation and reprogramming, cancer,
assisted reproductive technology (ART), and cognition. This
article will review the state-of-the-art in genomic imprinting and
XCI, focusing on recent advances in studying mechanism,
the emerging roles of lncRNAs, and their relevance for under-
standing and treating various human conditions.
X Chromosome Inactivation and Genomic Imprinting
Genomic Imprinting
Mammals require both maternal and paternal genomic contribu-
tions to develop into healthy, viable organisms (Solter, 1988).
This is, in large part, due to the inheritance of autosomally im-
printed genes, which are expressed only from a single allele in
accordance with its parent of origin (Bartolomei, 2009). That is,
imprinted genes are expressed either from the maternally or
paternally inherited allele, so that, when summed across the
whole genome, contributions from both parents are necessary
for expression of the full complement of imprinted genes and
for proper development. The elegant nuclear transplantation
experiments by Solter and Surani in the 1980s were the first
to suggest that the mammalian genome harbored imprinted
genes (McGrath and Solter, 1984; Surani et al., 1984). They
showed that diploid androgenetic embryos derived from two
male pronuclei or diploid gynogenetic embryos derived from
two female pronuclei failed to develop and reasoned that this
must be due to genes that are expressed exclusively from one
of the parental genomes. Later genetic experiments extended
these findings by demonstrating that the proposed imprinted
Figure 1. Mechanisms of Imprinting
(A)The insulator model is exemplified by the H19/Igf2 domain. Here, the in-
tergenic ICR is paternally methylated. On the unmethylated maternal allele,
CTCF binding prevents enhancers from interacting with the Igf2 promoter.
Instead, the enhancers activate H19 expression. On the paternal allele,
methylation of the ICR spreads to the H19 promoter, silencing its expression,
and prevents CTCF from binding the ICR, allowing the enhancers to activate
Igf2 expression.
(B–D) The ncRNA model is illustrated by the Kcnq1 (B), Igf2r (C), and Snprn (D)
domains.
(B) For Kcnq1, the ICR contains the promoter of the Kcnq1ot1 lncRNA. On the
paternal allele, the ICR is unmethylated, allowing Kcnq1ot1 expression.
Kcnq1ot1 expression silences the paternal allele of the linked genes in cis. On
the maternal allele, Kcnq1ot1 is not expressed due to methylation of the ICR,
and the adjacent imprinted genes are expressed.
(C) For the Igf2r domain, transcription of the Airn lncRNA is governed by
a promoter within the ICR and is expressed from the unmethylated paternal
allele. In somatic cells, transcription of Airn over the Igf2r promoter precludes
Igf2r expression, in part by kicking RNA polymerase II (POL-II) off of the
promoter. In extraembryonic lineages, Airn lncRNA is postulated to recruit
enzymes that confer repressive histone modifications to silence genes in cis.
(D) The Snrpn locus uses the ncRNA model. Ube3a is expressed from the
maternal allele exclusively in brain (in other tissues, it is biallelically expressed).
The lncRNA on the paternal allele occurs in multiple, variably processedgenes mapped to specific mouse chromosomes (Searle and
Beechey, 1978; Cattanach, 1986).
The current number of imprinted genes in the mouse is
approximately 150 (http://www.mousebook.org/catalog.php?
catalog=imprinting), with a smaller number identified in humans,
in part because many genes have not been tested in humans
(Weksberg, 2010). The imprinted genes are typically located
in clusters of 3–12 (or more) genes that are spread over 20–
3,700 kb of DNA (Barlow, 2011), but, interestingly, genes within
one cluster are not necessarily expressed from the same
parental chromosome (Figure 1). Most imprinted clusters contain
protein coding genes and noncoding RNAs (ncRNAs). The
ncRNAs are of different varieties (microRNAs, snoRNAs, and
lncRNAs), some of which are essential to the mechanism that
imprints these genes in cis. Each well-studied cluster has a
discrete imprinting control region (ICR) that exhibits parent-of-
origin-specific epigenetic modifications (DNA methylation and
posttranslational histone modifications) and governs the
imprinting of the locus. Although the mechanism(s) that confer
the allele-specific epigenetic modifications is poorly understood,
DNA methylation has been shown to be imposed at a precise
time in germ cells by a mechanism that is postulated to involve
transcription (Chotalia et al., 2009; Henckel et al., 2012) and is
maintained after fertilization despite extensive reprogramming
of the genome (Bartolomei and Ferguson-Smith, 2011) (Figure 1).
Moreover, germline deletion of the ICR results in the loss of
imprinting of multiple genes in the cluster, thus demonstrating
that the clustering of imprinted genes is required for their appro-
priate expression.
Many imprinted genes undergo tissue-specific imprinting. Of
the approximately 150 imprinted genes identified in mouse,
a few are imprinted exclusively in the placenta, an extraembry-
onic organ that plays a crucial role in regulating fetal growth by
controlling the supply of nutrients (Frost and Moore, 2010).
Imprinting is hypothesized to be a mechanism to balance
growth, with many imprinted genes having a demonstrated
role in growth control. Thus, the placenta is particularly signifi-
cant in the physiology and study of imprinting. Interestingly, as
described below, mechanisms that control imprinting in the
placenta—a short-lived organ—may differ from those mecha-
nisms that regulate imprinting in the much longer-lived somatic
lineages. This holds true not only for autosomal but also X-linked
imprinting.
X Chromosome Inactivation
In 1949, Murray Barr showed that the sex of cat cells could be
deduced by a subnuclear structure now called the ‘‘Barr body’’
in honor of his seminal work (Barr and Bertram, 1949). Susumuforms, some of which are brain-specific variants that contain upstream
promoters/exons and sequences overlapping withUbe3a. Expression of these
lncRNAs occurs when the ICR is unmethylated, with the result that expression
ofUbe3a is repressed. On the maternal allele, transcription of the upstream (U)
exons is proposed to direct the maternal methylation imprint at the ICR.
Topoisomerase I inhibitors identified by amouse screen activate Ube3a on the
paternal allele. As a result, Snprn and Ube3a-ATS were no longer expressed
and the ICR exhibited increased methylation, relative to the wild-type paternal
allele.
All imprinted domains, which are not drawn to scale, are depicted for
the mouse, although the human regions are largely conserved. T refers to the
telomeric end of the cluster and C the proximal end of the chromosome.
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Figure 2. The X-Inactivation and X-Reactivation Cycle during Mouse Development
Mammalian dosage compensation occurs within a continual cycle of XCI and X reactivation. The XCI cycle begins in the male germline. During the first meiotic
prophase of spermatogenesis, the X and Y undergo MSCI. After meiosis, 85% of X-linked genes remain suppressed through spermiogenesis, forming
postmeiotic sex chromatin (PMSC). This germline-inactivated X has been proposed to be passed onto the next generation in a partially silent state, accounting for
the preferential XP inactivation of the early female mouse embryo. In the two-cell mouse embryo, repetitive elements on XP are already suppressed. XP-linked
coding genes are initially active but become progressively inactivated during preimplantation development. The maternal germline also plays a crucial role
in imprinted XCI by marking the future XM during the oocyte growth phase, ensuring that XM is protected in both XX and XY embryos. Beyond the blastocyst,
these marks persist only in the placenta of the mouse. Whereas extraembryonic tissues, including the primitive endoderm (PE) and the trophectoderm (TE),
maintain imprinted XP inactivation, the epiblast lineage undergoes XCR and initiates zygotically driven random XCI. XCR also occurs in primordial germ cells
(PGCs) in preparation for equal segregation during meiosis. Xp, paternal X; Xm, maternal X; Xa, active X; MSCI, meiotic sex chromosome inactivation. Adapted
from Payer and Lee, 2008.Ohno later demonstrated that the Barr body is a condensed
X chromosome (Ohno et al., 1959), and Mary Lyon followed
with the understanding that the condensed X is the result of
whole-chromosome silencing (Lyon, 1961). We now know that
XCI compensates for dosage differences between males and
females by rendering all cells functionally monosomic for the
X chromosome (reviewed in Payer and Lee, 2008; Starmer and1310 Cell 152, March 14, 2013 ª2013 Elsevier Inc.Magnuson, 2009; Wutz, 2011). XCI is coordinated by an X-inac-
tivation center (Xic), which controls most, if not all, of the steps of
XCI, including X chromosome counting, random X chromosome
choice, and the initiation of silencing along 1,000 genes of the
X (Brown et al., 1991b) (Figure 2). These steps are completed in
the peri-implantation embryo within the 10–20 cell epiblast
lineage (which gives rise to all somatic cells) (Puck et al., 1992).
Once established, the pattern of XCI is stably propagated in the
soma, with the same X chromosome maintained as Xi in subse-
quent mitotic divisions. The mammalian female is therefore
a mosaic (Figure 2).
Whereas the choice of XCI in somatic cells of eutherian
mammals occurs randomly, the choice in marsupial mammals
is fixed. In marsupials (Sharman, 1971), and also in the extraem-
bryonic tissues of some eutherian mammals (Takagi and Sasaki,
1975), the paternal X (XP) is imprinted to undergo silencing,
providing a first example of mammalian imprinting. The phenom-
enon is conceptually similar to autosomal imprinting in that
monoallelic expression is determined by parent-of-origin and
has mechanistic underpinnings in the parental germline. Im-
printed XCI in the placenta adds to the number of imprinted
mammalian genes and further supports the idea that imprinting
balances fetal growth by controlling the nutrient supply (Frost
and Moore, 2010).
Mammalian dosage compensation occurs within a continual
cycle of XCI and reactivation (XCR) (Figure 2). Although random
XCI is female-specific, X silencing also occurs in the male germ-
line (Lifschytz and Lindsley, 1972). For somemammals, the male
germline is where the XCI cycle begins. During the first meiotic
prophase of spermatogenesis, the X and Y undergo ‘‘meiotic
sex chromosome inactivation’’ (MSCI) and form the ‘‘XY
body’’. The X and Y do not wholly reactivate after completion
of meiosis; in mice, 85% of genes on the X chromosome remain
transcriptionally suppressed in postmeiotic spermiogenesis
(Namekawa et al., 2006). This ‘‘postmeiotic sex chromatin’’
(PMSC) is decorated by distinct heterochromatic signatures
(Greaves et al., 2006; Namekawa et al., 2006; Turner et al.,
2006) and is consistent with the hypothesis that the germline-
inactivated X may be passed onto the next generation at least
in a partially preinactivated state, accounting for the preferential
XP inactivation that occurs in the early female embryo (Cooper,
1971; Lyon, 1999; Huynh and Lee, 2003).
At zygotic gene activation in the two-cell mouse embryo,
transcription of repetitive elements on XP is already suppressed,
reflecting their suppression in the male germline (Namekawa
et al., 2006; Namekawa et al., 2010) (Figure 2). Although X-linked
coding genes on the XP are initially active, they are progressively
inactivated during preimplantation development (Okamoto and
Heard, 2006; Kalantry et al., 2009; Namekawa et al., 2010).
The X-linked repetitive elements may facilitate formation of the
silent compartment for inactivation of XP genes (Namekawa
et al., 2010). Thus, imprinted XCI may be a process that begins
in the male germline, continues into the zygote as repeat
silencing, and progresses through the blastocyst stage with
genic silencing. However, the maternal germline also plays
a crucial role in imprinted XCI by marking the future XM to resist
silencing (Takagi and Abe, 1990; Goto and Takagi, 2000). This
occurs during the oocyte growth phase (Tada et al., 2000),
ensuring that XM (passed onto both XX and XY embryos) is pro-
tected (Figure 2). Thus, it is likely that both XP and XM are paren-
tally marked, with XP subject to imprinted XCI and XM protected
from it.
Beyond the blastocyst, these marks persist only in the
placenta of the mouse (Figure 2). The blastocyst consists of
the trophectodermal lineage, which gives rise to placental tissue,and the inner cell mass, which gives rise to the epiblast lineage
that develops into the embryo proper. During peri-implantation
development, their epigenetic fates diverge with respect to
XCI. Whereas extraembryonic tissues, including the primitive
endoderm (PE) and the trophectoderm (TE), maintain imprinted
XP inactivation, the epiblast lineage undergoes XCR and initiates
a new round of inactivation—this time randomly without
a parent-of-origin bias (Mak et al., 2004).
Mechanisms
Cis-Acting Control Regions
Both XCI and genomic imprinting are regulated by cis-acting
master control regions. For XCI, a single Xic has been mapped
to a 100–500 kb region (Brown et al., 1991b; Lee et al., 1999b;
Chureau et al., 2002) (Figure 3A). Genetic analyses based on
knockouts, gain-of-function mutations, and transgenic
overexpression have shown that the Xic is necessary and
sufficient to regulate XCI. Deleting the noncoding locus Xist
results in loss of silencing capability in cis (Penny et al., 1996;
Marahrens et al., 1997), and placing theXic at an ectopic location
results in counting, choosing, and silencing of the autosome (Lee
et al., 1996; Migeon et al., 1999; Wutz et al., 2002). The Xic there-
fore drives XCI without a requirement for additional X-specific
elements, such as those that might be responsible for the spread
of silencing.
Similarly, genomic imprinting is regulated by cis-acting ICRs
that influence allelic expression across long distances. Whereas
the Xic controls 150 Mb of a chromosome, ICRs control gene
clusters of 0.1–3.0 Mb. Within the clusters, the direction of
transcription and distribution of maternally versus paternally
imprinted genes can vary (Figure 1). However, nearly all im-
printed clusters studied to date contain at least one each of
maternally expressed and paternally expressed genes. ICRs
are usually just a few kilobases in length with allele-specific
DNA methylation and chromatin modifications, but their ICR’s
location relative to the genes can also vary. Most ICRs are meth-
ylated in the female germline during oocyte growth (Bartolomei
and Ferguson-Smith, 2011). A few, including the ICRs for the
H19/Igf2 and Gtl2/Dlk1 clusters, are methylated on the paternal
allele prior to birth in the male germline (Bartolomei and Fergu-
son-Smith, 2011) (Figure 1A). Maternally methylated ICRs
typically harbor the promoter for lncRNAs, examples of which
include the ICRs for Kcnq1ot1, Snprn, and Airn (Figures 1B–
1D). In contrast, paternally methylated ICRs are intergenic
(Barlow, 2011). In the case of the H19/Igf2 locus, the ICR serves
as a methylation-sensitive insulator (Figure 1A). In all cases, ICR
deletions result in the loss of imprinting of multiple genes within
the cluster.
Long Noncoding RNAs
The X-Inactivation Center. Noted early in the study of both
phenomena, a prominent feature of the Xic and ICRs is their
association with lncRNAs, the prototypes of which were dis-
covered within these regions (Brannan et al., 1990; Borsani
et al., 1991; Brown et al., 1991a; Lee et al., 1999a; Koerner
et al., 2009). With respect to function and mechanism, the Xic
harbors some of the best-characterized lncRNAs. The ‘‘X-inac-
tive-specific transcript’’ (XIST/Xist) (Brockdorff et al., 1992;
Brown et al., 1992) produces a 17–20 kb RNA that decoratesCell 152, March 14, 2013 ª2013 Elsevier Inc. 1311
Figure 3. The Control Center and Steps of Initiation during X Chromosome Inactivation
(A) The X-inactivation center consists of multiple genes encoding lncRNA, including Xist, RepA, Tsix, Xite, Jpx/Enox, Ftx, and Tsx. Regions involved in various
steps of XCI (counting, choice, pairing, and silencing) are delineated.
(B) Converging pathways of RNA-protein interactions during XCI. Yellow ovals represent chromatin complexes (PRC2, YY1, DNMT3a, RNF12, and REX1) that
interact with indicated lncRNA or associated loci. Positive regulation shown by pointed arrows; negative regulation shown by blunted arrows. Various steps of
XCI are shown in blue lettering.
(C) Initiation of XCI by lncRNA. (1) Biallelic Tsix prevents loading of RepA-PRC2 and initiation of XCI; (2) Two events enable Xist expression during cell differ-
entiation: induction of the Jpx activation andmonoallelic loss of Tsix on Xi, which allows RepA-PRC2 to load; (3) Xist cotranscriptionally recruits PRC2. YY1 binds
Xi nucleation center, but is blocked from binding Xa; (4) Xist-PRC2 complex cotranscriptionally loads onto the YY1-based nucleation center; (5) From the
nucleation center, Xist-PRC2 spreads in a cis-limited fashion to 150 strong Polycomb stations, which in turn spread H3K27me3 via 3,000–4,000 moderate
Polycomb sites.the X chromosome during the initiation of XCI (Clemson et al.,
1996). Xist is expressed only from the Xi and is required for
whole-chromosome silencing (Penny et al., 1996; Marahrens
et al., 1997). Xist RNA directs chromatin and transcriptional
change by binding Polycomb repressive complex 2 (PRC2),
the epigenetic complex responsible for trimethylation of histone
H3 at lysine 27 (H3K27me3), and targeting PRC2 to the Xi (Zhao
et al., 2008) (Figure 3B). This discovery suggests RNA as a crucial
guiding factor in Polycomb targeting. However, PRC2 targeting
and binding to the chromatin are biologically separable, as
indeed chromatin loading is precluded when Xist’s antisense
partner, Tsix (Lee et al., 1999a), is expressed in cis (Zhao et al.,
2008). Only when Tsix expression is downregulated during
development does the Xist-PRC2 complex load onto the Xi
‘‘nucleation center’’ within Xist’s exon 1 (Jeon and Lee, 2011).
The nucleation center consists of three binding sites for the
transcription factor, YY1, a protein bound only to the Xi allele.
By cotranscriptionally tethering Xist RNA to the Xic, YY1 bridges
PRC2, Xist RNA, and Xi chromatin (Figure 3B).
From the nucleation center, PRC2 spreads initially to 150
strong binding sites along the future Xi, concentrating predomi-1312 Cell 152, March 14, 2013 ª2013 Elsevier Inc.nantly within bivalent domains coinciding with CpG islands
(Pinter et al., 2012) (Figure 3C). As XCI proceeds, the coating
of the future Xi by Xist RNA correlates with recruitment of
3,000–4,000 moderate Polycomb sites, most of which are inter-
genic, nonbivalent, and lack CpG islands. The moderate sites
cluster around strong sites and facilitate the spreading of
H3K27me3 in a graded concentration relative to strong sites.
Interestingly, Polycomb stations are not enriched for the LINE1
repeats previously hypothesized to influence spreading (Lyon,
2003; Chow et al., 2010). Thus, the spreading of XCI is also
controlled by Xist RNA and is governed by a hierarchy of defined
Polycomb stations along the Xi.
Xist is itself controlled by other lncRNAs, some acting
negatively (e.g., Tsix), others positively (e.g., Jpx). Tsix RNA,
the antisense partner of Xist RNA (Lee et al., 1999a), represses
Xist in several ways. First, Tsix coordinates X chromosome
pairing to generate the epigenetic asymmetry required for
selection of future Xa and Xi (Bacher et al., 2006; Xu et al.,
2006; Xu et al., 2007). Second, Tsix also recruits DNA methyl-
transferase (Dnmt3a) to silence Xist (Sado et al., 2005;
Sun et al., 2006). Third, it blocks recruitment of PRC2 to Xist
(and RepA, see below), potentially by binding PRC2 and titrating
it from Xist/RepA RNAs (Zhao et al., 2008). Tsix also duplexes
with Xist/RepA RNA (Ogawa et al., 2008) and possibly serves
as decoy for PRC2 recruitment (by titrating Xist-RepA RNA or
PRC2). In these ways, Tsix determines allelic choice by repres-
sing Xist transcription on one allele (Figure 3B).
Xist is regulated positively by Jpx RNA (Tian et al., 2010)
(Figure 3C). Deleting Jpx abolishes Xist activation, indicating
that Jpx is a positive regulator. Because knocking down the
RNA recapitulates the deletion, Jpx must function as an RNA
and not merely through its act of being transcribed. Moreover,
because Jpx expression from an autosomal transgene can
rescue the X-linked deletion, Jpx RNA is trans acting, unlike
other elements of the Xic. The 1.6 kb RepA RNA (intragenic to
Xist) has also been implicated as a potential activator of Xist
expression, as its expression appears to be necessary for Xist
upregulation (Zhao et al., 2008) and deleting the Repeat A motif
(Hoki et al., 2009) abolishes Xist induction. The linked noncoding
Ftx locus has also been suggested to regulate Xist, as deleting
Ftx in male cells has mild effects on the chromatin profile of
Xist (Chureau et al., 2011), but its effects in female cells are
currently unknown. These Xist regulators work in parallel with
the E3 ubiquitin ligase, RNF12, encoded by an X-linked gene
near the Xic (Figures 3A and 3B): Its overexpression causes
partial derepression of Xist (Jonkers et al., 2009), and knockouts
of Rnf12 block imprinted XCI and delay random XCI (Shin et al.,
2010; Barakat et al., 2011). The pluripotency factor, REX1, has
been identified as a target of RNF12 (Gontan et al., 2012). It is
thought that elimination of REX1 binding to the Xist promoter
facilitates activation of Xist. These studies collectively point to
central functions for lncRNA-protein interactions, with the
lncRNAs targeting epigenetic complexes, serving as antisense
inhibitors, and activating sense transcription.
Imprinting Clusters. Every imprinted cluster harbors lncRNAs
(Figure 1), many of which originate within or near ICRs. These
lncRNAs are themselves imprinted. The most common mecha-
nism used for imprinting relies on expression of a lncRNA in cis
and exploits much of what has been identified for silencing of
the X chromosome during XCI (Figure 1). There are currently
six well-characterized clusters of imprinted genes (along with
at least nine additional less well-studied clusters), including
Igf2r/Airn, Kcnq1, Snprn/Ube3A, Gnas, Igf2/H19, Dlk1/Gtl2
(Barlow, 2011). All of these clusters contain lncRNAs. Three
imprinted lncRNAs are long mature RNAs: Airn is 108 kb (Lyle
et al., 2000), Kcnq1ot1 is approximately 100 kb (Pauler et al.,
2012), and, Ube3a-ATS may be in excess of 1,000 kb (Pauler
et al., 2012). The Gtl2 lncRNA contains multiple alternatively
spliced transcripts, however, downstream intergenic transcrip-
tion has also been noted, suggesting longer RNAs are likely
(Tierling et al., 2006). Nespas lncRNA exceeds 27 kb (Robson
et al., 2012).
Experiments that directly test the role of the lncRNA itself
have now been performed for a number of loci (Airn, Nespas,
Kcnq1ot1, and Ube3aats). Thus far, all have been analyzed by
genetic manipulation of the endogenous locus to truncate the
lncRNA by insertion of a polyadenylation signal. The 108 kb
Airn lncRNA has been examined in the most detail. Initially,
Barlow and colleagues reported that truncation of Airn to 3 kbin a mouse model suggested that the lncRNA itself is necessary
to silence all 3 mRNA genes in the Igf2r cluster, indicating a clear
regulatory role for this lncRNA (Sleutels and Barlow, 2002)
(Figure 1A). Similarly, truncation of the 100 kb Kcnq1ot1
lncRNA to 1.5 kb showed that this lncRNA was directly needed
to silence all 10 mRNA genes in the larger Kcnq1 cluster
(Mancini-Dinardo et al., 2006) (Figure 1B), and truncation of the
27 kb Nespas lncRNA showed it was necessary to silence
the overlappedNesp gene in theGnas imprinted cluster (William-
son et al., 2011). Lastly, truncated Ube3a-ATS in an embryonic
stem (ES) cell model resulted in activation of paternal Ube3a
(Figure 1D), consistent with the role for the Ube3a-ATS lncRNA
in repressing paternal Ube3a in neurons (Meng et al., 2012)
(Figure 1).
At this point, it is not clear how the lncRNAs silence imprinted
genes in cis. One possibility is that they overlap adjacent im-
printed genes and the sense-antisense overlap causes a form
of transcriptional interference of a promoter or an enhancer,
which in turn affects transcription from the mRNA promoter
(Pauler et al., 2012). In this case, the first event could be silencing
of the overlapped promoter or enhancer followed by accumu-
lation of repressive chromatin that can spread and induce
transcriptional gene silencing throughout the cluster. Evidence
for this model was recently obtained by Latos and colleagues
by generating a series of recombinant endogenous chromo-
somes at the Igf2r/Airn locus in ES cells (Latos et al., 2012)
(Figure 1C). Analogous to XCI, the onset of allele-specific
expression at this locus in the embryo can be recapitulated
by ES cell differentiation, where Igf2r is initially biallelically ex-
pressed but the initiation of Airn expression results in Igf2r
imprinting (Latos et al., 2009). To test whether Airn transcription
or the lncRNA itself was required for Igf2r silencing, Airn was
shortened to different lengths and it was shown that silencing
only required Airn transcription overlap of the Igf2r promoter,
which interferes with RNA polymerase II recruitment (Latos
et al., 2012). This model suggests that Airn acts predominantly
through its transcription, rather than as a lncRNA like Xist.
It is, however, also possible that imprinted lncRNAs act by
coating the local chromosomal region and directly recruiting
repressive chromatin proteins to the imprinted cluster, in a
manner similar to Xist lncRNA. Many imprinted lncRNAs, such
as Gtl2 and Nespas, appear to form a complex with Polycomb
proteins (Pandey et al., 2008; Zhao et al., 2010). Evidence for
a function of the lncRNA in recruitment of histone posttrans-
lational modification machinery comes from experiments in
placental tissues. RNA fluorescence in situ hybridization ex-
periments showed that Airn and Kcnq1ot1 form RNA clouds at
their site of transcription and are associated with a repressive
histone compartment and Polycomb proteins (Nagano et al.,
2008; Pandey et al., 2008; Terranova et al., 2008; Redrup
et al., 2009). This nuclear compartment is also devoid of RNA
polymerase II and exists in a three-dimensionally contracted
state. Other studies on the Airn lncRNA go further in suggesting
that the lncRNAs actively recruit repressive histone modifica-
tions (Nagano et al., 2008) but only in the placenta. In this latter
case, Airn was shown to actively recruit the histone H3 lysine
9 methyltransferase, G9a, and paternal-specific silencing of
the Slc22a3 gene but not the Igf2r gene, was dependent onCell 152, March 14, 2013 ª2013 Elsevier Inc. 1313
Figure 4. LncRNAs Tether Epigenetic Complexes to Chromatin, Enabling Allelic, and Locus-Specific Regulation
(A–C) LncRNA transcribed by RNA polymerase II (POL-II) (A) cotranscriptionally binds to an epigenetic complex (such as PRC2) (B), which loads onto chromatin
through DNA-bound factors such as YY1 (for Xist RNA) (C).
(D) Epigenetic modifications silence the linked gene. Rapid lncRNA turnover prevents diffusion and action at ectopic loci. Adapted from Lee, 2012.G9a—in a mechanism that contrasts with the promoter-
transcription model hypothesized on the basis of transcript
truncation experiments in somatic lineages (Latos et al., 2012).
These experiments indicate that lncRNA mediated silencing of
imprinted genes may depend on different downstream mecha-
nisms.
A new class of lncRNAs was recently discovered, sno-
lncRNAs, that arise from the imprinted Prader-Willi Syndrome
(PWS) critical region of human chromosome 15 (Yin et al.,
2012). Intriguingly, these lncRNAs, which have a snoRNA
sequence at each end as well as intervening sequence, accumu-
late near the sites of synthesis and strongly associate with Fox
family splicing regulators and alter splicing. The investigators
hypothesize that the sno-lncRNAs in the PWS locus function
as molecular sinks for Fox2, acting locally to alter splicing
patterns in specific subnuclear neighborhoods. Thus, the mech-
anisms by which lncRNAs operate at imprinted loci are diverse.
Why Are lncRNAs Central to Imprinting and XCI?. It has been
argued that lncRNAs make ideal factors for allelic regulation
(Lee, 2012). Indeed, lncRNA’s tethering capabilities and potential
for fast turnover renders them excellent allelic markers. These
transcripts are tethered to the site of synthesis through the
RNA polymerase II transcription complex and can therefore
function as allele-specific tags (Figure 4). As shown by Xist and
RepA RNA, such long transcripts can cotranscriptionally capture
chromatin complexes while tethered to the site of transcription
(Zhao et al., 2008). Tethering could be aided by bridge proteins,
such as YY1 in the case of Xist RNA (Jeon and Lee, 2011). Rapid
RNA turnover after transcription would prevent diffusion to
ectopic sites. At the Xic, the decoying effect of Tsix for Polycomb
proteins would be limited to the Xic by Tsix’s very short half-life
(30–60 min, the time required to synthesize the 40 kb RNA;
Sun et al., 2006) so that effective concentrations would only be
reached at the site of synthesis. Whereas lncRNAs can mark
alleles, proteins cannot retain such allelic memory because
their transcriptional origin is lost when mRNA is shuttled to the
cytoplasm.
Another property of lncRNAs is their ability to specify a unique
address (Lee, 2012). Although transcription factors can also
recruit epigenetic complexes, lncRNAs offer the possibility of
targeting to a single location. Transcription factors typically
target complexes to multiple genomic locations because they
recognize short DNA motifs that occur hundreds to thousands
of times in the genome. In contrast, lncRNAs such as Tsix and
RepA/Xist occur only once in the genome. Because of this1314 Cell 152, March 14, 2013 ª2013 Elsevier Inc.uniqueness, lncRNAs can deliver epigenetic complexes to
a single address, offering a regulatory specificity not possible
with proteins or small RNAs. These properties may explain why
the protein-coding region syntenic to the present-day Xic was
rapidly transformed into a noncoding landscape 150 million
years ago when random XCI first appeared in eutherian
mammals (Duret et al., 2006). Prior to this time, Xist was a
ubiquitin ligase, Lnx3, and Jpxwas a peptidase,UspL1. It is likely
that lncRNAs evolved within imprinted domains and other
locations in the mammalian genome for similar reasons. For
a discussion of genome-wide lncRNAswith epigenetic functions,
we refer readers to the accompanying Review by Batista and
Chang on page 1298 of this issue (Batista and Chang, 2013).
Insulators
Despite the common occurrence of lncRNAs at imprinted loci,
insulators may play an equally important role in imprinted
regions. The insulator model, which has been described at the
Igf2/H19 locus (Figure 1A), is an evolutionarily older mechanism,
components of which are conserved in marsupials (Smits et al.,
2008). Key to this mechanism is CTCF-binding sites in the ICR,
which exhibit insulator or enhancer blocking properties (Bell
and Felsenfeld, 2000; Hark et al., 2000). On the maternal allele,
CTCF binds to the ICR and blocks the access of Igf2 to
enhancers shared with H19, which are located downstream,
thereby allowing H19 exclusive enhancer access. On the
paternal allele the ICR acquires DNA methylation in the male
germline, preventing CTCF binding, allowing Igf2 interaction
with the enhancers and paternal-specific expression (Fig-
ure 1A). The presence of DNA methylation on the paternal ICR
leads to secondary methylation of the H19 promoter and
paternal-specific H19 silencing (Thorvaldsen et al., 1998). The
involvement of CTCF in the insulator model has prompted the
identification of CTCF-binding sites at other imprinted genes
such as Rasgrf1, Grb10, and Kcnq1ot1, indicating that the
insulator model may operate in other imprinted clusters. CTCF
sites have also been identified within the Xic in regions important
for imprinted XCI (Chao et al., 2002); however, it is currently
unknown if CTCF is central to imprinting the X. Insulator-based
and lncRNA-based models are not mutually exclusive.
The Enigma of Imprinted XCI
Imprinted XCI in the Mouse
A further consideration of imprinted XCI is worthwhile for its
mechanistic differences and implications for human develop-
ment. The mechanism of X-imprinting not only differs from
Figure 5. Imprinted XCI in the Mouse
(A) Pictorial representation of genic localization into the preformed silent compartment during imprinted XCI. XP repeats form a silent compartment next to the
nucleolus by the two-cell stage and, although Xist RNA localizes within it, formation of this silent compartment does not require Xist. The repeats could potentially
contribute to imprinted XCI by setting up a silencing compartment next to the nucleolus. The silent compartment is present by the two-cell stage and enlarges as
genic loci are translocated into it and become silenced. Genic silencing depends on Xist. XP silencing is completed by the blastocyst.
(B) Pictorial representation of XP and XM in the early mouse embryo. Repeat elements of XP create the silent perinucleolar compartment, whereas XM and active
genic loci of XP reside in repeat-expressing regions.
(C) Hypothesis: developmental history of the X chromosome from gamete to embryo. Hypothesized events in imprinted XCI of the mouse are shown. In the male
germline, during the first meiotic prophase, the X and Y are inactivated by MSCI and remain suppressed through spermiogenesis as PMSC. This germline-
inactivated X may be passed onto the next generation with its repeats preinactivated. In the two-cell mouse embryo, repetitive elements on XP are already
suppressed in an Xist-independent manner. XP genic silencing occurs progressively during preimplantation development, strictly depends on Xist, and is
completed in the blastocyst stage. Thus, imprinted XCI in the mouse embryo is a two-step process, with repeat silencing (Xist-independent) occurring prior to
genic silencing (Xist-dependent). Repeat silencing could account partly for the transgenerational information (the imprint) involved in XP silencing. The maternal
germline also plays a crucial role in imprinted XCI by marking the future XM.
Adapted from Namekawa et al. (2010).random XCI but also differs between the imprinted marsupial
and eutherian forms. In mouse imprinted XCI, XP-repeat
silencing precedes genic inactivation (Figure 5A) (Namekawa
et al., 2010). The repeats form a silent compartment next to the
nucleolus by the two-cell stage and, although Xist RNA localizes
within it, formation of this silent compartment does not require
Xist. Repeats could potentially contribute to imprinted XCI
by setting up a silencing compartment next to the nucleolus
(Figure 5B). If their silencing were indeed carried over from the
male germline, repeats could account partly for the transgene-
rational information (the imprint) for XP silencing.XP genic silencing follows repeat silencing (Namekawa et al.,
2010) and occurs predominantly in the morula-blastocyst stages
(Okamoto and Heard, 2006; Namekawa et al., 2010). Although
one study suggests an Xist-independent process (Kalantry
et al., 2009), the general consensus is that genic silencing
depends on Xist (Marahrens et al., 1997; Namekawa et al.,
2010). Xist must be marked by a second (presently unknown)
imprint that would promote imprinted genic XCI (Figure 5C). In
the mouse, Xist and Tsix are opposing regulatory factors for
imprinted genic silencing, as they are for random XCI. Deleting
Xist from XP precludes placental XCI (Marahrens et al., 1997),Cell 152, March 14, 2013 ª2013 Elsevier Inc. 1315
whereas deleting Tsix from XM compromises maternal-specific
protection from imprinted silencing in the placenta (Lee, 2000;
Sado et al., 2001). Thus, the Xic plays at least a partial role in
imprinted XCI in eutherian mammals.
Imprinted XCI in Marsupials
The eutherian Xic is not recognizable in the marsupial (Duret
et al., 2006). The idea of an Xist-independent mechanism based
on repeat silencing raises the possibility of a similar mechanism
in marsupials. Notably, the opposum male germline demon-
strates postmeiotic silencing of X-linked repeat elements (Name-
kawa et al., 2007), but whether silencing is carried over into the
embryo is unknown. The recent identification of RSX indicates
that a lncRNA like XIST may be present (Grant et al., 2012).
The 27 kb RSX transcript also ‘‘coats’’ the marsupial Xi and
is specifically expressed in female cells. Introduction of RSX
transgenes into mouse ES cells results in partial silencing of
three autosomal genes near the site of integration. These find-
ings suggest that RSX may be the XIST equivalent in opposum,
though an RSX knockout has not been performed and the two
lncRNAs do not possess obvious homology. Like in the mouse,
an XIC mechanism may occur alongside a repeat-silencing
process to implement imprinted XCI.
Imprinted XCI in Humans?
The question of whether imprinted XCI occurs in the human
placenta has not been resolved, but implications for human
development are evident. In several studies, examination of
single X-linked genes from a small number of placentae sug-
gested preferential maternal expression (e.g., Harrison and
Warburton, 1986). Using transdifferentiation of a female human
ES line into trophoblast cells, another study found that FMR1
was expressed only from one X, consistent with imprinting
(Dhara and Benvenisty, 2004). However, other studies have
detected expression from both XM and XP (Moreira de Mello
et al., 2010; Okamoto et al., 2011; Pen˜aherrera et al., 2012);
and, in a nonhuman primate model, XIST was detected from
either XM or XP of the trophectoderm (Tachibana et al., 2012).
The fact that the X chromosome contributing to Turner (XO)
and Klinefelter (XXY) syndrome could be of either XM or XP origin
(Skuse et al., 1997; Skuse, 2000, 2005) further argues against
imprinting. Although the preponderance of evidence may be
against imprinted XCI in human placentae, there is the intriguing
possibility of X-imprinting in the brain as a basis for male-female
differences in behavior and prevalence of autism (Skuse, 2000)
(more below). The question of imprinting therefore bears sig-
nificance for human development and disease, particularly
where X-linked mutations may contribute to early fetal loss,
and congenital or cognitive defects.
Human Diseases and Conditions
Congenital Diseases of Imprinting
Because of parental-origin effects, human disease syndromes
can result from genetic or epigenetic abnormalities on only
a single parental allele. In fact, most well-defined imprinted
gene clusters are associated with human diseases (Thorvaldsen
and Bartolomei, 2007). Interestingly, aberrant expression of
ICR-associated lncRNAs may be implicated in various imprint-
ing disorders. Two of the best-studied imprinting syndromes,
PWS and Angelman (AS) syndromes, map to human chromo-1316 Cell 152, March 14, 2013 ª2013 Elsevier Inc.some 15 (Buiting, 2010). PWS involves loss of function of
a number of genes on 15q11-13, including SNORD116. People
with PWS are obese and have reduced muscle tone and mental
ability. AS syndrome is a complex disorder of the nervous
system that arises from loss of function of the UBE3A gene
(Figure 1D). AS symptoms include delayed development, intel-
lectual disability, and severe speech impairment. Most PWS
and AS cases involve large deletions containing the imprinted
genes from the chromosome on which they are expressed. In
PWS, there is biallelic repression of the ICR-associated lncRNA;
in AS, the lncRNA is biallelically expressed. A smaller number
of cases arise from either deletion or aberrant allelic DNA
methylation of the ICR, leading to expression changes. With
the recent identification of the new class of lncRNAs, sno-
lncRNAs, it is likely that absence of the sno-lncRNA in the
PWS critical region impairs brain-specific splicing possibly due
to mislocalization of Fox splicing factors.
Beckwith-Wiedemann syndrome (BWS), an overgrowth
disorder, and Silver-Russell syndrome (SRS), an undergrowth
and asymmetry disorder, are two other well-studied imprinting
disorders that map to human chromosome 11p15.5, where
IGF2 and H19 reside (Figure 1A). Unlike PWS and AS, the
majority of individuals with BWS or SRS have epigenetic errors.
For example, over half of BWS cases exhibit loss of methylation
at the KCNQ1 ICR, which results in biallelic expression of the
KCNQ1OT1 lncRNA (Weksberg et al., 2005) (Figure 1B). Inappro-
priate expression of the lncRNA may lead to aberrant repression
of associated disease genes in cis—in this case, CDKN1C was
silenced. Additionally, some BWS patients exhibit overexpres-
sion of IGF2. Most of these cases have small deletions in the
ICR on the maternal allele, which disrupts the CTCF-dependent
insulator, leading to biallelic IGF2 and loss of H19 expression
(Riccio et al., 2009). Curiously, the remaining ICR sequences in
these individuals are hypermethylated. Many individuals with
SRS have an opposite epigenetic phenotype where the ICR is
unmethylated, resulting in biallelic H19 expression and loss of
IGF2 expression. In many of these cases, it is unclear what event
leads to DNA hypomethylation but in some cases, multiple
imprinted loci exhibit loss of ICR methylation (Azzi et al., 2010).
Significantly, some examples of multilocus loss of imprinting
involve mutations in ZFP57, a zinc finger protein involved in the
postfertilization maintenance of genomic imprints, which was
first reported in individuals presenting with transient neonatal
diabetes (Mackay et al., 2008). It is possible that yet-to-be
identified proteins are mutated in other cases involving loss of
methylation. Alternatively, early environment insults can affect
DNA methylation patterns (see Imprinting and Assisted Repro-
ductive Technology as an example).
X-Linked Influences on Disease, Cognition,
and Behavior
The X chromosome is home to nearly 1,000 genes, many of
which result in discernible human phenotypes when mutated.
X-linked diseases result from single-gene mutations, which can
be classified as dominant or recessive, with the former manifest
in both XX and XY individuals and the latter manifest primarily in
XY individuals because they lack a wild-type allele. X-linked
mutations can cause serious disease, such as hemophilia
A (FVIII), Duchenne muscular dystrophy (DMD), Rett syndrome
(MECP2), and fragile X syndrome (FMR1), or less serious con-
ditions, such as red-green color blindness and male-pattern
baldness. Because of differential inheritance of sex chromo-
somes and the hemizygous state of the X chromosome in the
male population, more diseases have been described for the
X chromosome than any other (Puck and Willard, 1998).
As X-linked genes have existed in the hemizygous state for
much of the history of sex chromosomes, the X chromosome
has been engaged in selection of sexually dimorphic traits for
more than 300 million years since the X and Y began to diverge
(Arnold et al., 2004; Skuse, 2005). Genes for sexual dimorphism,
reproduction, and cognition are enriched on the X chromosome,
with their genetic patency making them easy substrates for
evolutionary selection. In mice, deleting the Xic-encoded
lncRNA, Tsx, has been shown to reduce fear and enhance hippo-
campal short-term memory in male mice (Anguera et al., 2011).
The fact that many X-linked genes are expressed in the brain,
some in a sex-specific manner, may explain why mental retarda-
tion and autism are up to ten times more common in males,
though the underlying mutations are not known for many such
disorders (Skuse et al., 1997). Genetic patency of X-linked
haplotypes has been hypothesized to increase the likelihood of
manifesting extreme behavioral and cognitive phenotypes in
males, and the likelihood would also be increased in females
when the XCI pattern is skewed to favor XM expression. XCI
profiles and mosaicism vary extensively between human
females, perhaps accounting for greater phenotypic variation
among females (Carrel and Willard, 2005). Genes that variably
escape XCI also contribute to this effect (Berletch et al., 2011).
In the mouse, X-linked modifiers such as the Xce can skew XCI
ratios (Cattanach and Isaacson, 1967; Percec et al., 2002;
Thorvaldsen et al., 2012), providing a mechanism by which
nonrandom XCI patterns could be generated. Nonrandom XCI
is also not uncommon in human females (Puck and Willard,
1998).
In the area of cognitive and behavioral development, the study
of X chromosome monosomies (XO, Turner syndrome) has
played a major role in elucidating X-linked contributions. Turner
syndrome girls usually have normal verbal intelligence but are
less developed in spatial and mathematical skills. By comparing
Turner syndrome girls who inherited their X chromosome from
mother (XMO) versus father (XPO), one study concluded that
the XP was associated with enhanced social cognitive function
(Skuse et al., 1997). Despite their genotypic similarity, the epige-
netically different XPO and XMO girls demonstrated measurable
phenotypic differences in social adjustment. The fact that the
XP chromosome is normally only inherited by daughters has
led some to suggest that it accounts for better social skills in
girls on average. XPO and XMO girls also exhibit differences in
visual memory and brain structure (Bishop et al., 2000; Kesler
et al., 2004). Candidate genes include USP9X, MAOA, and
MAOB (monoamine oxidases) on the short arm of the human
X chromosome (Good et al., 2003; Oreland et al., 2004).
Genes on the X chromosome may be imprinted tissue specif-
ically, particularly in the brain where many X-linked genes are
expressed. A transcriptome analysis of the mouse brain sug-
gested that hundreds of alleles on XM may be preferentially
expressed in glutamatergic neurons of the female cortex (Gregget al., 2010). Although XP alleles are not silenced, they are ex-
pressed at lower levels. This type of partial imprinting could
contribute to cognitive and behavioral differences. Follow-up
analyses have argued that the allelic skewing called by whole-
transcriptome analyses may have been an aberration caused
by unappreciated statistical limitations of a novel technology
(DeVeale et al., 2012; reviewed in Kelsey and Bartolomei,
2012). Thus, the question of how many and in what tissues im-
printed X-linked genesmay occur in eutherianmammals remains
open. This clinically important area has been underexplored.
Xist, the X Chromosome, and Cancer
An association between the X chromosome and cancer has been
noted since the discovery of the Barr body (Moore and Barr,
1955; Liao et al., 2003; Pageau et al., 2007). Breast and ovarian
cancer cells, for example, frequently duplicate their Xa. The
correlation also holds for men, as XXY men have a 20- to 50-
fold increased risk of breast cancer in a BRCA1 background
(Fentiman et al., 2006), and testicular germ cell tumors often
acquire supernumerary Xs (Kawakami et al., 2003). One recent
study directly tested the connection of the X to cancer by condi-
tionally deleting Xist RNA in the blood lineages of mice (Yildirim
et al., 2013). This deletion resulted in overexpression of the
X chromosome and a fulminant hematologic cancer known as
‘‘mixed MPN/MDS’’ (myeloproliferative neoplasm, myelodys-
plastic syndrome), a cancer that includes chronic myelomono-
cytic leukemia, erythroleukemia, histiocytic sarcoma, and bone
marrow fibrosis. The cancer is female specific and 100% pene-
trant. Intriguingly, in humans, MDS is more common in women,
with noted XIST deletions and X chromosome duplications
occurring in MPN, MDS, and myeloid cancers (see references
within Yildirim et al., 2013). The association is not restricted
to women, as extra X chromosomes are seen in a range of
leukemias in both sexes. The mouse study showed that loss
of Xist perturbed maturation as well as longevity of hematopoi-
etic stem cells. Thus, Xist plays a role not only in dosage
compensation but also in suppressing cancer and preserving
function of adult stem cell populations. This study illustrates
the importance of studying lncRNA function not only in cells
ex vivo but also within the context of the organism in vivo.
Epigenetic Reprogramming in Human Stem Cells
Xist RNA also influences the pluripotent stem cell population, as
shown by recent studies of induced pluripotent stem cells (iPSC)
in regenerative medicine. In mice, XCI is tightly linked to cell
differentiation in the epiblast and the possession of two Xa is
a hallmark of pluripotent cells of both mouse ESC and iPSC
(reviewed in Minkovsky et al., 2012). The tight linkage is ex-
plained by the physical convergence of many pluripotency
factors, such as OCT4, SOX2, NANOG, and REX1, at the Xic,
specifically within control regions of Xite, Tsix, and Xist (Navarro
et al., 2008; Donohoe et al., 2009; Navarro et al., 2010)
(Figure 3B). Binding of pluripotency factors to these regions
blocks initiation of XCI, and the loss of binding during cell differ-
entiation creates a permissive state for the initiation of XCI.
XIST currently provides one of a few tangible readouts for
stem cell quality. In human ESC (hESC) and iPSC (hiPSC),
XIST expression and XCI do not necessarily occur in the
expected manner. Female hESC and hiPSC lines occur in
three different epigenetic groups based on XIST expressionCell 152, March 14, 2013 ª2013 Elsevier Inc. 1317
(Silva et al., 2008) (Minkovsky et al., 2012). ‘‘Class I’’ cells are
most similar to mESC in that they have two Xa in the undifferen-
tiated state. When placed in differentiation conditions, Class I
cells express XIST and initiate XCI. In contrast, ‘‘Class II’’ cells
already express XIST and carry one Xi, even before growth under
differentiation conditions. Finally, ‘‘Class III’’ cells once ex-
pressed XIST but irreversibly lost its expression, with evidence
of partial X reactivation (Shen et al., 2008; Silva et al., 2008;
Anguera et al., 2012; Tomoda et al., 2012). Epigenetic fluidity is
evident through irreversible progression from Class I to II to III
states (Tchieu et al., 2010; Anguera et al., 2012; Mekhoubad
et al., 2012). Class I is transient, whereas Class III is dominant
and stable.
Although failure of XIST expression is lethal in vivo (Penny
et al., 1996; Marahrens et al., 1997), loss of XIST does not
have the same dire consequences ex vivo, though these cells
lack full developmental potential (Silva et al., 2008; Anguera
et al., 2012). Class III hiPSCs have limited differentiation
capability (Anguera et al., 2012; Mekhoubad et al., 2012), In a
xenograft model, Class III hiPSCs produce cystic teratomas
composed of simple cystic epithelia and undifferentiatedmesen-
chyme, whereas Class II cells produce well-differentiated struc-
tures of three germ layers. Given the tumorigenic phenotype of
the murine Xist deletion (Yildirim et al., 2013), most concerning
would be the potential of XIST-negative hIPSC lines to cause
cancer when introduced in vivo in the clinical setting. Indeed,
Class III hiPSC also showed partial X reactivation, faster
doubling times, and a distinct gene expression signature of
cancer cells (Anguera et al., 2012), urging further careful consid-
eration before using hiPSCs in regenerative medicine.
Genomic imprinting also contributes to quality of human and
mouse iPSC (Pick et al., 2009; Sun et al., 2012). The imprinted
state of the imprinted Dlk1-Dio3 locus—in particular the expres-
sion of Gtl2 (aka Meg3) lncRNA—has been at the center of
attention. One study found that mouse iPSC cloneswith aberrant
Dlk1-Dio3 imprinting and low Gtl2 expression contributed
poorly to chimeras (Stadtfeld et al., 2010), whereas another did
not observe a difference (Carey et al., 2011). There is, however,
general agreement that loss of imprinting at this locus resulted
in lower efficiency of generating entirely iPSC-derived mice
(Stadtfeld et al., 2010; Carey et al., 2011; Stadtfeld et al.,
2012). With further investigation, it is likely that other imprinted
loci will affect stem cell quality. Nonetheless, despite a number
of claims that imprinting is aberrant, iPSCs can be an important
tool for studying imprinting perturbations in inaccessible cell
types such as neurons in AS (Chamberlain et al., 2010).
Imprinting and Assisted Reproductive Technology
Related to the issue of epigenetic change within imprinted and
X-linked loci in stem cells ex vivo is the question of whether
in vitro culture of early human embryos during use of ART might
have similar effects on imprinting and XCI. The ex vivo manipu-
lations utilized during ART coincide with the developmental
stages in which genome-wide epigenetic reprogramming occurs
(i.e., oocyte growth and preimplantation development). The use
of ART procedures to help couples with fertility issues conceive
children of their own has doubled in the last decade. In 2009,
ART contributed to 1.4% of all U.S. births (Sunderam et al.,1318 Cell 152, March 14, 2013 ª2013 Elsevier Inc.2012). Nevertheless, there is growing concern about the safety
of these procedures (Manipalviratn et al., 2009). Of particular
concern, children conceived by ART have an increased inci-
dence of rare epigenetic disorders, with most of these patients
exhibiting loss of DNA methylation at ICRs (Manipalviratn et al.,
2009). Specifically, cases of AS and BWS in children conceived
by ART are associated with loss of methylation of the SNPRN
and KCNQ1 ICRs, respectively, which result in biallelic expres-
sion of the lncRNAs and loss of expression of UBE3A and
CDKN1C, respectively (Figure 1). Consistently, animal studies
have demonstrated that embryo culture and embryo transfer
as well as hormonal treatments, which are integral components
of ART, disrupt normal epigenetic programming in embryonic
and extraembryonic lineages (Mann et al., 2004; Fortier et al.,
2008; Rivera et al., 2008), although the mechanism for this
disruption remains poorly understood. Thus, a greater under-
standing of in vitro effects on epigenetic regulation during ART
is a rising need from a public health perspective of industrialized
countries.
Conclusions and Therapeutic Prospects
XCI, genomic imprinting, and lncRNA clearly havemajor implica-
tions for public health. Yet, in the arena of preventive, diagnostic,
and therapeutic medicine, few strategies have targeted regula-
tory factors for imprinted genes and the Xic to control X-linked
disease and conditions. This holds true also for regenerative
medicine and stem cell biology, where ex vivo cellular manipula-
tions have not universally considered the impact of imprinting
and XCI, in spite of converging indications that these processes
impact production, maintenance, and overall quality of stem
cells.
On a hopeful note, proof-of-concept was reported in one
recent study. One of the most intriguing aspects of disorders
that involve monoallelically expressed genes is the prospect
for therapy that involves derepressing the silenced allele
in situations where the expressed allele of an imprinted gene is
deleted or contains a loss of function mutation. A recent success
was reported for AS, where a screen revealed that small mole-
cule topoisomerase inhibitors reactivated the silenced UBE3A
gene and repressed the ICR-associated antisense RNA (Huang
et al., 2012). Ironically, however, because of the clustering of
imprinted genes, the biallelic activation ofUBE3Awas accompa-
nied by the loss of expression of the paternally-expressed genes
in the locus (Figure 1D). Although the mechanism for reactivation
is unclear, these strategies offer hope and suggest that other loci
could be subject to similar screens.
The successful reactivation of the silent copy of UBE3A raises
hopes that a treatment for various X-linked diseases might be
similarly achieved. Of particular interest has been Rett
syndrome, a neurologic disorder caused by mutations in
MECP2. The syndrome affects girls and is manifested by
a reversal of developmental milestones after the first year of
life (the disease is fatal in newborn males). Because Rett
syndrome is not accompanied by neurodegeneration, efforts
have been devoted to restoring expression of MECP2 after birth
in hopes of reversing the symptoms. Intriguingly, mouse models
have shown that restoration of MECP2 expression after disease
first becomes symptomatic can reverse the neurologic defects
(Giacometti et al., 2007; Guy et al., 2007). Because the possibility
that restoration of MECP2 expression might similarly cure
Rett syndrome in humans, ongoing studies are now aimed at
reactivating the wild-type copy of MECP2 in affected girls
through small molecules that target chromatin modifiers and
other regulators of XCI and XCR.
Furthermore, with knowledge that loss of XIST expression
and/or overdosage of the X chromosome could result in blood
cancer (Yildirim et al., 2013), cancer therapeutics might similarly
be directed at genes on the X chromosome. In the future, in addi-
tion to trans-acting factors such as topoisomerases, therapeutic
strategies could be targeted at control regions (ICRs, Xic) or
lncRNAs that regulate crucial genes in cis. For example, it may
be productive to determine ways to control expression of XIST
RNA, GTL2, and other imprinted genes. We may be some
ways from realizing commercial products, but the technologies
to develop them are evolving rapidly and may soon enable us
to produce drugs to influence cellular reprogramming ex vivo
and to treat human diseases and conditions in vivo.
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